Search

Your search keyword '"Verfaillie, Sander C.J."' showing total 235 results

Search Constraints

Start Over You searched for: Author "Verfaillie, Sander C.J." Remove constraint Author: "Verfaillie, Sander C.J."
235 results on '"Verfaillie, Sander C.J."'

Search Results

1. Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer’s Disease

6. Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia

7. Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease—Data from three memory clinic studies

8. Neuropsychological functioning after COVID-19: minor differences between individuals with and without persistent complaints after SARS-CoV-2 infection.

9. Longitudinal tau binding in tau‐PET negative patients with clinical Alzheimer’s disease

10. The association between AD biomarkers and neuropsychiatric symptoms in subjective cognitive decline; the SCIENCe project

11. Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia With Lewy Bodies

12. Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer’s Disease

13. Computer-assisted prediction of clinical progression in the earliest stages of AD

16. ATN classification and clinical progression in subjective cognitive decline: The SCIENCe project

20. A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer’s Disease Continuum

22. Predicting cortical thickness with [18F]flortaucipir PET: A longitudinal MRI study.

23. Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET

25. [ 18 F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers

26. Correction to: Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 47, 12, (2866-2878), 10.1007/s00259-020-04758-2)

27. Correction to:Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 47, 12, (2866-2878), 10.1007/s00259-020-04758-2)

28. 18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers

29. Amyloid and Tau Pathology Associations With Personality Traits, Neuropsychiatric Symptoms, and Cognitive Lifestyle in the Preclinical Phases of Sporadic and Autosomal Dominant Alzheimer’s Disease

30. Regional tau pathology is associated with loss of synapses and reduced synaptic activity: A combined [18F]flortaucipir, [11C]UCB‐J and magnetoencephalography study

31. Early‐onset Alzheimer’s disease is related to differential spatial patterns of tau pathology and cognitive impairment

32. Tau pathology, relative cerebral flow and cognition in dementia with Lewy bodies

33. Grey zone amyloid burden heralds future memory decline: The SCIENCe Project

34. PARAMETRIC IMAGING OF [18F]FLORBETAPIR: A TEST-RETEST STUDY IN HEALTHY SUBJECTS AND PATIENTS WITH ALZHEIMER’S DISEASE

35. O5‐01‐03: EARLY TAU PET PATHOLOGY IS ASSOCIATED WITH MEMORY PERFORMANCE IN COGNITIVELY UNIMPAIRED INDIVIDUALS WITH SCD: THE SCIENCE PROJECT

36. F1‐04‐03: ATN BIOMARKER MODEL AS A DETERMINANT OF COGNITIVE DECLINE AND INCIDENT CLINICAL PROGRESSION IN SUBJECTIVE COGNITIVE DECLINE: THE SCIENCE PROJECT

37. P4‐316: LONGITUDINAL DYNAMIC [18F]FLORTAUCIPIR PET REVEALS INCREASED EARLY STAGE TAU PATHOLOGY IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE

39. IC‐P‐184: LONGITUDINAL DYNAMIC [18F]FLORTAUCIPIR PET REVEALS INCREASED EARLY STAGE TAU PATHOLOGY IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE

40. P2-375: A STUDY TO EVALUATE THE KINETICS AND 28 DAY TEST-RETEST REPEATABILITY AND REPRODUCIBILITY OF THE RADIOLIGAND [11 C]UCB-J FOR BRAIN PET IMAGING IN HEALTHY SUBJECTS AND MILD-MODERATE ALZHEIMER'S DISEASE SUBJECTS

41. P1-412: [18 F]FLORTAUCIPIR BINDING STRONGLY CORRELATES TO COGNITION ACROSS THE CLINICAL ALZHEIMER'S DISEASE CONTINUUM, INDEPENDENTLY OF CSF TAU

42. IC‐P‐187: [18F]FLORTAUCIPIR BINDING STRONGLY CORRELATES TO COGNITION ACROSS THE CLINICAL ALZHEIMER'S DISEASE CONTINUUM, INDEPENDENTLY OF CSF TAU

43. Dietary Patterns Are Related to Clinical Characteristics in Memory Clinic Patients with Subjective Cognitive Decline: The SCIENCe Project

45. [18F]Flortaucipir PET Across Various MAPTMutations in Presymptomatic and Symptomatic Carriers

46. Regional distribution of tau pathology in cognitively unimpaired, genetically identical twins: Neuroimaging / Normal brain aging.

47. Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease—Data from three memory clinic studies

49. O2‐06‐03: AMYLOID‐β LOAD IS RELATED TO WORRIES IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE

50. IC‐P‐111: [ 18 F]FLORBETAPIR‐SPECIFIC BINDING IN RELATION TO COGNITION IN SUBJECTIVE COGNITIVE DECLINE

Catalog

Books, media, physical & digital resources